Abstract:High content antibody microarrays are powerful tools to evaluate alterations in the levels and post‐translational status of hundreds of proteins of interest with only microgram amounts of crude cell and tissue lysate protein. However, interpretations of the results from traditional antibody microarray approaches have been hampered by the problems associated with sample preparation and protein detection, even when potent and specific antibodies are printed on these arrays. The Kinex™ KAM‐900P and KAM‐1150E antibody microarrays permitted semi‐quantitative measurements of the expressions, post‐translational modifications, and interactions of proteins with as little as 25 μg of lysate proteins. When used in combination, these microarrays utilize approximately 1250 different pan‐specific and 600 phosphosite‐specific antibodies for tracking protein kinases, phosphatases and other low abundance regulatory proteins involved in cell growth, stress responses and apoptosis. With diverse detection protocols, these microarrays enable high density profiling of lysate protein levels, phosphorylation and ubiquitination, and protein‐protein interactions in diverse experimental model systems, including human tumour cells in response to epidermal growth factor (EGF) and insulin treatment. One method involved the capture of in vitro biotin‐labeled lysate proteins, followed by their detection with dye‐labeled anti‐biotin antibody. False positive signals from associated proteins in complexes with the targets were reduced by chemical cleavage at cysteine residues with 2‐nitro‐5‐thiocyanatobenzoic acid (NTCB) prior to their capture on the array, and this also produced more uniformity of the dye signals for protein targets despite vast differences in their sizes. Transient changes in protein phosphorylation in EGF treated cells that were typically lost when processed by conventional methods were better preserved by chemical cleavage right at time of sample homogenization, and the chemically cleaved samples were stable for weeks without the need for refrigeration or freezing. Biotin‐labelling and subsequent detection of the antibody‐captured proteins on the arrays with a dye‐labeled anti‐biotin antibody reduced non‐specific background signals, allowed for a greater dynamic range of detection of up to 10,000‐fold, and enhanced discrimination of subtle changes in protein expression or phosphorylation. In conjunction with other detection protocols, such as the usage of dye‐labeled reporter antibodies for generic protein‐tyrosine phosphorylation in sandwich antibody microarrays (SAM format) or generic protein phosphorylation with nanoparticles such as pAMIGO (PAM format), it is also feasible to monitor changes in general phosphorylation of low abundance cell signalling proteins. The SAM format can also be adapted to identify target proteins that are subjected to other types of covalent modification such as ubiquitination and how these are altered when appropriate dye‐labelled covalent modification‐specific antibodies are deployed to probe the KAM‐900P and KAM‐1150E antibody microarrays. Furthermore, the SAM format has been used to monitor the interactions of complexed scaffolding, adaptor and chaperone proteins with signalling proteins that are captured on the antibody microarrays with specific, dye‐labelled reporter antibodies for the interacting proteins. Support or Funding Information This research was funded by Kinexus Bioinformatics Corporation, and LY was supported by a studentship award from the National Sciences and Engineering Research Council of Canada. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Phosphorylated Protein Chip Combined with Artificial Intelligence Tools for Precise Drug Screening

High-Throughput Phosphotyrosine Protein Complexes Screening by Photoaffinity-Engineered Protein Scaffold-Based Forward-Phase Protein Array

Photoaffinity-engineered Protein Scaffold for Systematically Exploring Native Phosphotyrosine Signaling Complexes in Tumor Samples

High-Throughput Phosphorylation Screening and Validation Through Ti(IV)-Nanopolymer Functionalized Reverse Phase Phosphoprotein Array.

Peptide microarrays for high-throughput studies of Ser/Thr phosphatases

Phosphopeptide Microarrays for Comparative Proteomic Profiling of Cellular Lysates

High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display

Mapping Nanoscale‐To‐Single‐Cell Phosphoproteomic Landscape by Chip‐DIA

Rapid, Multiplexed Phosphoprotein Profiling Using Silicon Photonic Sensor Arrays.

Sensitive Approaches for the Assay of the Global Protein Tyrosine Phosphorylation in Complex Samples Using a Mutated SH2 Domain.

High-Throughput Screening of Substrate Specificity for Protein Tyrosine Phosphatases (ptps) on Phosphopeptide Microarrays.

High-Throughput and Integrated Chemical Proteomic Approach for Profiling Phosphotyrosine Signaling Complexes

Integrated and High-Throughput Approach for Sensitive Analysis of Tyrosine Phosphoproteome

Tracking Protein Expression, Post‐translational Modifications and Interactions with High Content Antibody Microarrays

Activity‐based High‐throughput Determination of PTPs Substrate Specificity Using a Phosphopeptide Microarray

Real-time monitoring of dephosphorylation process of phosphopeptide and rapid assay of PTP1B activity based on a 100 MHz QCM biosensing platform

Proteomic Sensors for Quantitative, Multiplexed and Spatial Monitoring of Kinase Signaling

High-throughput Screening of Catalytically Inactive Mutants of Protein Tyrosine Phosphatases (ptps) in a Phosphopeptide Microarray

Profiling Signaling Protein Expression, Modifications and Interactions with Multi‐dimensional Antibody Microarrays

Nanomediator-Effector Cascade Systems for Amplified Protein Kinase Activity Imaging and Phosphorylation-Induced Drug Release In Vivo

A Tyrosine Phosphoproteome Analysis Approach Enabled by Selective Dephosphorylation with Protein Tyrosine Phosphatase.